Article ID Journal Published Year Pages File Type
5703531 Archivos de la Sociedad Española de Oftalmología 2017 4 Pages PDF
Abstract
Intralesional administration of rituximab for treating primary FL of the conjunctiva was an effective and safe therapeutic option; therefore it could be an alternative to other conventional treatments, such as radiotherapy or chemotherapy.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Preview
Rituximab intralesional como tratamiento de linfoma folicular primario de conjuntiva recidivante
Authors
, , ,